Two people in a business meeting.

PARTNER WITH US

No single organisation can solve cancer early detection alone. Partner with us and together we can accelerate research discoveries into better outcomes for people affected by cancer.

EXPANDING THE ALLIANCE

As we continue to grow, we welcome new members and partners who share our commitment to advancing cancer early detection through collaboration.

We’re interested in working with:

  • Research institutions, universities and funders seeking new research collaborations.

  • Independent researchers looking to get involved in research programmes.

  • Pharmaceutical and biotechnology companies looking to collaborate on research that advances innovative early detection interventions.

  • Philanthropists and impact investors searching for strategic investments with real-world impact.

Contact us to discuss partnering opportunities and join a community committed to impact.

Email aced@cancer.org.uk

BENEFITS OF PARTNERING WITH US

Access world-leading expertise

Engage with internationally recognised researchers across biology, technology and translation, all focused on accelerating cancer early detection.

Collaborate across a unique multi-centre alliance

Work within a coordinated network of centres designed to share knowledge, data and resources to drive progress faster than any single institution could.

Shape major research proposals

Contribute to the development of future international research programmes and help define the next generation of early detection science.

Support meaningful patient and public involvement and engagement

Support research that involves people affected by cancer at every stage of the research process — from initial study design to implementation and outcomes.

OUR ALLIANCE AT A GLANCE

£50m+

Invested in the Alliance since launch in 2019

300+

People working collaboratively across our member centres

75+

Collaborative grants

Professor Michael Baumann, Chairman and Scientific Director, German Cancer Research Center (DKFZ).

International collaborations provide a platform for sharing resources, knowledge, and expertise across borders. By fostering partnerships between institutions, researchers, policymakers and patients, ACED can accelerate progress and ensure that early detection strategies are widely accessible.

- Michael Baumann, DKFZ Chairman and Scientific Director

LEADERSHIP AND RESEARCH EXCELLENCE